UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000005568
Receipt number R000006147
Scientific Title A randomized phase II study of efficacy of risendronate for the prevention of letrozole-induced bone mineral loss in post-menopausal breast cancer patients
Date of disclosure of the study information 2011/05/07
Last modified on 2020/03/13 00:06:40

No. Disposal Last modified on Item of update
1 Insert 2011/05/07 14:01:32
2 Update 2013/05/07 09:05:13 Post marketing survey by drug manufacture etc., specified by Japanese law.
3 Update 2013/05/07 09:07:27 Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
4 Update 2020/03/11 22:56:09 UMIN ID1
5 Update 2020/03/13 00:01:06 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Division name
Zip code
Address
Email

Last name of contact person

Last name of contact person
Division name
Zip code
Address
Email
Name of primary person or sponsor
Organization
Organization1
Tel1
Email1
Organization
Organization
Address
Address
Tel
Email
6 Update 2020/03/13 00:02:32 Institute
Institute
Organization
Organization
7 Update 2020/03/13 00:06:40 Recruitment status
Date of IRB